Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

Benzinga
05-03

iRhythm Technologies Inc (NASDAQ:IRTC) on Thursday reported first quarter 2025 revenue of $158.7 million, up 20.3% year over year, beating the consensus of $153.38 million.

The increase was driven by growth in demand for Zio services.

The company reported an adjusted EPS loss of 95 cents, down from a loss of $1.23 a year ago, beating the consensus estimate of 98 cents.

Gross profit was $109.2 million, up 24.8% from $87.5 million during the same period in 2024, while gross margin was 68.8%, up from 66.3% during the same period in 2024.

  • The increase in gross profit was primarily due to the increased volume of Zio services provided due to higher demand.
  • The increase in gross margin was primarily due to volume leverage and operational efficiencies, partially offset by an increased blended cost per unit from a higher Zio AT product mix.

Quentin Blackford, CEO of iRhythm, noted the company’s recent commercial launch in Japan for a total of six markets outside the U.S.

On Thursday, iRhythm announced the commercial launch of its Zio long-term continuous ECG monitoring (LTCM) system, commercially introduced in Japan as the Zio ECG Recording and Analysis System.

Guidance: iRhythm projects fiscal 2025 sales guidance of $690 million-$700 million, compared to prior guidance of $675 million-$685 million and consensus of $681.56 million.

William Blair writes, “We view updates this quarter as further validation of our thesis playing out this year as Zio AT accelerates, management executes on its land and expand strategy, and the company is seeing early positive signals in adjacent opportunities.”

  • Analyst Margaret Kaczor Andrew maintains the Outperform rating.
  • Wells Fargo upgrades iRhythm Technologies from Equal-Weight to Overweight, raising the price target from $104 to $130.
  • Baird maintains iRhythm with an Outperform rating, raising the price target from $133 to $150.
  • Needham maintains iRhythm with a Buy, raising the price target from $138 to $151.

Price Action: IRTC stock is up 19.1% at $129.37 at the last check Friday.

Read Next:

  • LendingTree’s Mixed Q1 Earnings: Sharply Slashes Full-Year Forecast, Stocks Dive Premarket Friday

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10